NCT00623064View on ClinicalTrials.gov

Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

DRUG

lapatinib ditosylate

OTHER

pharmacological study

Trial Locations (1)

2100

Rigshospitalet - Copenhagen University Hospital, Copenhagen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00623064 - Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer | Biotech Hunter | Biotech Hunter